Prevalence of metabolic syndrome and diabetes mellitus type 2 under the conditions of the primary component of public health
Barno Shagazatova, Viktoria Stareva & Gavhar Mukhiddinova
Background and aims: The metabolic syndrome (MS) pathology, that is in the center of the attention of endocrinologists, cardiologists and therapeutics, is frequently diagnosed with the development of vascular complications, or of diabetes mellitus type 2 (DMT2).
The aim of the present study is to investigate the occurrence of MS, according to IDF (2005) and DMT2 according to criteria WHO (1999) under the conditions of the primary component of public health.
Materials and methods: The study of MS and DMT2 were conducted on the base of family polyclinic No. 37 in Tashkent-city in 2008. By random sampling method, there were selected two sectors, where the people older than 35 years, living within the area, operated by this polyclinic fell under the overall observation. Totally there were examined 628 people.
If body mass index (BMI) ≥30 kg/m2 and more the diagnosis of obesity is made. DMT2 and impaired glucose tolerance (IGT), 75-g glucose, were diagnosed according to the WHO (1999) classification. The checkup showed dyslipidemia (DL): total cholesterol (TCH) ≥5.2 mmol/l; triglyceride (TG) ≥1.7 mmol/l. Waist circumference (Wc) is more then ≥94 cm males and ≥80 cm females; abdominal index (AI) ≥0.95 for the men and ≥0.8 for the women is defined as abdominal obesity (AO). MS was diagnosed at the presence of all the four criteria and/or central obesity and two additional criteria IDF (2005).
Results: The investigation showed that among the checked up the occurrence of MS with its different components reached 9.6%. The people with DMT2 were not included. The newly revealed patients with DMT2 amounted to 4.1%.
Conclusion: Thus, the investigation showed that the occurrence of the MS under the dispensary-polyclinic conditions composed 9.6%, DMT2 4.1%.